Skip to main content

Casdin Capital, LLC

Location
New York, NY
Portfolio Value
Mid $1,320,653,767
Diversification
Diversified
Filing Date
Global Rank
#1,273 / 8,232 ▲ 361
Top Industry
Biotechnology 53.4%
3Y Alpha vs SPY
-9.9%
Period ended 2 months ago
Filed May 15, 2026 · 30d
24 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+36.5%
SPY
+76.3%
Annualised alpha
-9.9%
Max drawdown
−39.3%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

40 positions · as of Mar 31, 2026 · Δ vs Sep 30, 2025
Top Position
19.0%
−9.9 pts
Top 5
59.3%
−10.2 pts
Top 10
77.3%
−8.3 pts
HHI
903
Mar 2023 → Mar 2026 · range 848 – 1,603
Diversified−468

Portfolio Trend

24 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 100.0% $1,320,653,767

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Sep 30, 2025

Added To

Positions the filer increased
9 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
4 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
13 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
4 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
40 positions · $1,320,653,767 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History